From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis
Recent advances in SSL enabled novel medical AI models, known as foundation models, offer great potential for better characterizing health from diverse biomedical data. CGM provides rich, temporal data on glycemic patterns, but its full potential for predicting broader health outcomes remains underu...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recent advances in SSL enabled novel medical AI models, known as foundation
models, offer great potential for better characterizing health from diverse
biomedical data. CGM provides rich, temporal data on glycemic patterns, but its
full potential for predicting broader health outcomes remains underutilized.
Here, we present GluFormer, a generative foundation model for CGM data that
learns nuanced glycemic patterns and translates them into predictive
representations of metabolic health. Trained on over 10 million CGM
measurements from 10,812 adults, primarily without diabetes, GluFormer uses
autoregressive token prediction to capture longitudinal glucose dynamics. We
show that GluFormer generalizes to 19 external cohorts (n=6,044) spanning
different ethnicities and ages, 5 countries, 8 CGM devices, and diverse
pathophysiological states. GluFormers representations exceed the performance of
current CGM metrics, such as the Glucose Management Indicator (GMI), for
forecasting clinical measures. In a longitudinal study of 580 adults with CGM
data and 12-year follow-up, GluFormer identifies individuals at elevated risk
of developing diabetes more effectively than blood HbA1C%, capturing 66% of all
new-onset diabetes diagnoses in the top quartile versus 7% in the bottom
quartile. Similarly, 69% of cardiovascular-death events occurred in the top
quartile with none in the bottom quartile, demonstrating powerful risk
stratification beyond traditional glycemic metrics. We also show that CGM
representations from pre-intervention periods in Randomized Clinical Trials
outperform other methods in predicting primary and secondary outcomes. When
integrating dietary data into GluFormer, we show that the multi-modal version
of the model can accurately generate CGM data based on dietary intake data,
simulate outcomes of dietary interventions, and predict individual responses to
specific foods. |
---|---|
DOI: | 10.48550/arxiv.2408.11876 |